Apligraf: Clinical Trials

4 trials of Apligraf, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown, 1 withdrawn. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Apligraf: new trials by email Literature Review of Apligraf trials Research Report on Apligraf

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®
Apligraf - Venous Leg Ulcers
Phase 4UnknownOrganogenesis1002013-11-012013-12-13
A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa
Apligraf - Epidermolysis Bullosa, Wound Healing
Phase 4TerminatedUniversity Hospital, Basel, Switzerland32012-06-012015-03-10
A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers
Apligraf, Standard of Care Dressing Group - Venous Ulcer
Phase 4CompletedOrganogenesis302011-03-012015-09-24
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers
Apligraf - Varicose Ulcer
Phase 4WithdrawnOrganogenesis2008-07-012015-08-19

Conditions studied

Varicose Ulcer (2)  ·  Epidermolysis Bullosa (1)

Sponsors

Organogenesis (3)  ·  University Hospital, Basel, Switzerland (1)

Countries

United States (2)  ·  Switzerland (1)

Top investigators

Andreas Arnold, MD (1)  ·  Damien Bates, MD, PhD, FRACS (Plast.) (1)  ·  David G. Armstrong, DPM, MD, PhD (1)  ·  Evangelos Badiavas, MD, PhD (1)  ·  Scott Gorenstein, MD (1)  ·  William A. Marston, MD (1)

Results publications

PMID 28053158, PMID 31674093